Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

GW24-e2211 Protective effects of aliskiren on ischaemia-reperfusion-induced renal injury in rats

View through CrossRef
Objectives The protective effect of aliskiren on ischaemia-reperfusion (I/R) injury in the heart and brain has been reported. Whether or not the protective effect exists in renal I/R injury is not known. Therefore, we investigated this effect in kidney in this study. Methods Sprague-Dawley rats were randomly divided into four groups: sham group; sham control with aliskiren pretreatment; I/R group; I/R with aliskiren pretreatment. Renal ischaemia was induced by occluding the left renal pedicle, and maintained ischaemia for 45 min, the reperfusion lasted for 24 hrs. Aliskiren was administrated 15 min before ischaemia. Blood samples and the kidneys were collected to check for renal function, angiotensin II (Ang II), apoptosis and oxidative stress levels. Results Compared with the sham rats, serum creatinine (SCR) and blood urea nitrogen (BUN) were significantly increased in I/R rats, accompanied by histopathological damage ofthe kidney, including tubular cell swelling, desquamation, and cast formation. There were more apoptotic cells and leukocyte infiltration in I/R rats than in the sham rats. Pretreatment with aliskiren ameliorated I/R induced renalinjury, i.e. reduced SCR and BUN levels, ameliorated renal histopahological changes, and decreased the apoptosis of cells and leukocyte infiltration in kidney. I/R injury also decreased superoxide dismutase (SOD) and glutathione (GSH-reduced form) levels, which were blocked with the aliskiren pretreatment. Conclusions Aliskiren pretreatment exerts a protective effect on ischaemia/reperfusion injury in the kidney, via amelioration of oxidative stress, and reduction in leukocyte infiltration and cellular apoptosis.
Title: GW24-e2211 Protective effects of aliskiren on ischaemia-reperfusion-induced renal injury in rats
Description:
Objectives The protective effect of aliskiren on ischaemia-reperfusion (I/R) injury in the heart and brain has been reported.
Whether or not the protective effect exists in renal I/R injury is not known.
Therefore, we investigated this effect in kidney in this study.
Methods Sprague-Dawley rats were randomly divided into four groups: sham group; sham control with aliskiren pretreatment; I/R group; I/R with aliskiren pretreatment.
Renal ischaemia was induced by occluding the left renal pedicle, and maintained ischaemia for 45 min, the reperfusion lasted for 24 hrs.
Aliskiren was administrated 15 min before ischaemia.
Blood samples and the kidneys were collected to check for renal function, angiotensin II (Ang II), apoptosis and oxidative stress levels.
Results Compared with the sham rats, serum creatinine (SCR) and blood urea nitrogen (BUN) were significantly increased in I/R rats, accompanied by histopathological damage ofthe kidney, including tubular cell swelling, desquamation, and cast formation.
There were more apoptotic cells and leukocyte infiltration in I/R rats than in the sham rats.
Pretreatment with aliskiren ameliorated I/R induced renalinjury, i.
e.
reduced SCR and BUN levels, ameliorated renal histopahological changes, and decreased the apoptosis of cells and leukocyte infiltration in kidney.
I/R injury also decreased superoxide dismutase (SOD) and glutathione (GSH-reduced form) levels, which were blocked with the aliskiren pretreatment.
Conclusions Aliskiren pretreatment exerts a protective effect on ischaemia/reperfusion injury in the kidney, via amelioration of oxidative stress, and reduction in leukocyte infiltration and cellular apoptosis.

Related Results

GW24-e3848 The organ protective effect of direct renin inhibitor in a mouse model of type 2 diabetes
GW24-e3848 The organ protective effect of direct renin inhibitor in a mouse model of type 2 diabetes
Objectives The benefit of blocking the renin-angiotensin system (RAS) with conventional RAS blockers in cardiovascular diseases and nephropathy of patients with t...
A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension
A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension
Aliskiren is a novel antihypertensive agent and the first direct renin inhibitor (DRI) in clinical use. Several clinical trials have compared DRI with angiotensin receptor blockers...
e0123 The effect of diabetes on protection of ischaemic postconditioning in myocardial ischaemia-reperfusion injury
e0123 The effect of diabetes on protection of ischaemic postconditioning in myocardial ischaemia-reperfusion injury
Objective Study on the effect of diabetes on protection of ischaemia Postconditioning in myocardial ischaemia-reperfusion injury in isolated rat hearts. ...
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Objective To observe time dependent effects of simulated ischemia-reperfusion on transient sodium currents (INa) in rat left ventricular myocytes, and effects of ...
e0352 Efficacy and safety of aliskiren in chinese patients with mild or moderate essential hypertension
e0352 Efficacy and safety of aliskiren in chinese patients with mild or moderate essential hypertension
To assess the antihypertensive efficacy and safety of aliskiren compared with ramipril in Chinese patients with mild or moderate essential hypertension. ...

Back to Top